Csl Behring AG Sustainability Profile
CSL Behring AG, a global leader in biotherapeutics, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1904, the company has established itself in the biotechnology industry, specialising in the development and manufacture of innovative therapies for rare and serious diseases. CSL Behring is renowned for its high-quality plasma-derived products, including immunoglobulins, clotting factors, and albumin, which are essential for treating conditions such as haemophilia and immune deficiencies. The company’s commitment to research and development has led to significant advancements in patient care, positioning it as a trusted name in the healthcare sector. With a strong market presence and a dedication to improving patient outcomes, CSL Behring AG continues to achieve notable milestones, reinforcing its reputation as a pioneer in the biopharmaceutical landscape.
DitchCarbon Score
How does Csl Behring AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Csl Behring AG's score of 38 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Csl Behring AG's reported carbon emissions
In 2024, Csl Behring AG reported total carbon emissions of approximately 351,000,000 kg CO2e, a slight increase from about 336,000,000 kg CO2e in 2023. These figures encompass Scope 1 and 2 emissions, indicating the company's direct and indirect emissions from energy use. Csl Behring AG is a current subsidiary of CSL Limited, which influences its climate commitments and reporting. However, there are currently no specific reduction targets or initiatives disclosed by Csl Behring AG, nor are there any emissions data for Scope 3. The absence of reduction targets suggests that the company may be in the early stages of formalising its climate strategy. As part of its corporate family, Csl Behring AG may align with broader sustainability initiatives from CSL Limited, which is involved in various climate-related pledges and reporting frameworks. However, specific details on these initiatives were not provided in the available data.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | - | - |
| Scope 3 | - | - |
How Carbon Intensive is Csl Behring AG's Industry?
How Carbon Intensive is Csl Behring AG's Location?
Csl Behring AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Csl Behring AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
